97-5210. Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Amendment of Monograph for OTC Bronchodilator Drug Products; Correction  

  • [Federal Register Volume 62, Number 42 (Tuesday, March 4, 1997)]
    [Rules and Regulations]
    [Page 9684]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-5210]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 341
    
    [Docket No. 94N-0247]
    RIN 0910-AA01
    
    
    Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug 
    Products for Over-the-Counter Human Use; Amendment of Monograph for OTC 
    Bronchodilator Drug Products; Correction
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule; correction.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
    monograph for over-the-counter (OTC) bronchodilator drug products that 
    appeared in the Federal Register of May 20, 1996 (61 FR 25142). The 
    document amended the final monograph for OTC bronchodilator drug 
    products by removing pressurized metered-dose aerosol container dosage 
    forms for the ingredients epinephrine, epinephrine bitartrate, and 
    racepinephrine hydrochloride. The document was published with an 
    inadvertent error in one of the amendatory instructions. This document 
    corrects that error.
    
    EFFECTIVE DATE: March 4, 1997.
    
    FOR FURTHER INFORMATION CONTACT: LaJuana D. Caldwell, Office of Policy 
    (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 
    20857, 301-443-2994.
    
    SUPPLEMENTARY INFORMATION: In FR Doc. 96-12499, appearing on page 25142 
    in the Federal Register of Monday, May 20, 1996, the following 
    correction is made: On page 25146, in the 3d column, amendatory 
    instruction 4 is corrected to read as follows:
        4. Section 341.76 is amended by removing the heading for paragraph 
    (d)(2), and paragraphs (d)(2)(i) and (e), by redesignating paragraph 
    (d)(2)(ii) as paragraph (d)(2), and by revising the heading of newly 
    redesignated paragraph (d)(2) to read as follows:
    
        Dated: February 24, 1997.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 97-5210 Filed 3-3-97; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
3/4/1997
Published:
03/04/1997
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule; correction.
Document Number:
97-5210
Dates:
March 4, 1997.
Pages:
9684-9684 (1 pages)
Docket Numbers:
Docket No. 94N-0247
RINs:
0910-AA01: Over-the-Counter (OTC) Drug Review
RIN Links:
https://www.federalregister.gov/regulations/0910-AA01/over-the-counter-otc-drug-review
PDF File:
97-5210.pdf
CFR: (1)
21 CFR 341